scholarly journals Cost-Effectiveness of Quadrivalent Versus Trivalent Influenza Vaccine in the United States

2014 ◽  
Vol 17 (7) ◽  
pp. A679
Author(s):  
P.T. De Boer ◽  
R.J. Pitman ◽  
B. Macabeo ◽  
A. Chit ◽  
M.J. Postma ◽  
...  
Keyword(s):  
United States ◽  
Cost Effectiveness ◽  
Influenza Vaccine ◽  
The United States ◽  
Trivalent Influenza Vaccine

scholarly journals Cost-Effectiveness of Quadrivalent versus Trivalent Influenza Vaccine in the United States

2016 ◽  
Vol 19 (8) ◽  
pp. 964-975 ◽  
Author(s):  
Pieter T. de Boer ◽  
Pascal Crépey ◽  
Richard J. Pitman ◽  
Bérengère Macabeo ◽  
Ayman Chit ◽  
...  
Keyword(s):  
United States ◽  
Cost Effectiveness ◽  
Influenza Vaccine ◽  
The United States ◽  
Trivalent Influenza Vaccine

Cost-effectiveness of live attenuated influenza vaccine versus inactivated influenza vaccine among children aged 24–59 months in the United States

Vaccine ◽  
2008 ◽  
Vol 26 (23) ◽  
pp. 2841-2848 ◽  
Author(s):  
Bryan R. Luce ◽  
Kristin L. Nichol ◽  
Robert B. Belshe ◽  
Kevin D. Frick ◽  
Su Xia Li ◽  
...  
Keyword(s):  
United States ◽  
Cost Effectiveness ◽  
Influenza Vaccine ◽  
The United States ◽  
Live Attenuated Influenza Vaccine

scholarly journals Does Choice of Influenza Vaccine Type Change Disease Burden and Cost-Effectiveness in the United States? An Agent-Based Modeling Study

2017 ◽  
Vol 185 (9) ◽  
pp. 822-831 ◽  
Author(s):  
Jay V. DePasse ◽  
Kenneth J. Smith ◽  
Jonathan M. Raviotta ◽  
Eunha Shim ◽  
Mary Patricia Nowalk ◽  
...  
Keyword(s):  
United States ◽  
Cost Effectiveness ◽  
Influenza Vaccine ◽  
Disease Burden ◽  
The United States ◽  
Agent Based Modeling ◽  
Agent Based ◽  
Vaccine Type ◽  
Type Change ◽  
Modeling Study

Cost-Effectiveness of Inhaled Nitric Oxide in the Treatment of Neonatal Respiratory Failure in the United States

PEDIATRICS ◽  
2003 ◽  
Vol 112 (6) ◽  
pp. 1351-1360 ◽  
Author(s):  
D. C. Angus ◽  
G. Clermont ◽  
R. S. Watson ◽  
W. T. Linde-Zwirble ◽  
R. H. Clark ◽  
...  
Keyword(s):  
Nitric Oxide ◽  
United States ◽  
Cost Effectiveness ◽  
Respiratory Failure ◽  
The United States ◽  
Inhaled Nitric Oxide

scholarly journals Cost-effectiveness for KTE-X19 CAR T therapy for adult patients with relapsed/refractory mantle cell lymphoma in the United States

2021 ◽  
Vol 24 (1) ◽  
pp. 421-431
Author(s):  
Claire L. Simons ◽  
Daniel Malone ◽  
Michael Wang ◽  
Gregory A. Maglinte ◽  
Tim Inocencio ◽  
...  
Keyword(s):  
United States ◽  
Cost Effectiveness ◽  
Mantle Cell Lymphoma ◽  
Cell Lymphoma ◽  
The United States ◽  
Adult Patients ◽  
Car T ◽  
Mantle Cell
Sign in / Sign up

Export Citation Format

Share Document